Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Potassium 4-aminosalicylate
2. 133-09-5
3. Aminosalicylate Potassium
4. Monopotassium 4-aminosalicylate
5. Paskalium
6. Benzoic Acid, 4-amino-2-hydroxy-, Monopotassium Salt
7. Potassium;4-amino-2-hydroxybenzoate
8. 4-aminosalicylic Acid (potassium)
9. 7n21461lkd
10. Benzoic Acid, 4-amino-2-hydroxy-, Potassium Salt (1:1)
11. Einecs 205-090-7
12. Unii-7n21461lkd
13. Aminosalicylate Potassium [usp]
14. Potassium,4-amino-2-hydroxybenzoate
15. P-aminosalicylate Acid Potassium Salt
16. Potassium Paraaminosalicylate
17. Schembl1477512
18. Chembl1200584
19. Dtxsid3059634
20. P-aminosalicylic Acid Potassium Salt
21. Akos024323786
22. Potassium Aminosalicylate [orange Book]
23. P-aminosalicylic Acid Potassium Salt [mi]
24. Q27268591
| Molecular Weight | 191.23 g/mol |
|---|---|
| Molecular Formula | C7H6KNO3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 190.99847454 g/mol |
| Monoisotopic Mass | 190.99847454 g/mol |
| Topological Polar Surface Area | 86.4 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 165 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Aminosalicylate Potaium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aminosalicylate Potaium, including repackagers and relabelers. The FDA regulates Aminosalicylate Potaium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aminosalicylate Potaium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aminosalicylate Potaium supplier is an individual or a company that provides Aminosalicylate Potaium active pharmaceutical ingredient (API) or Aminosalicylate Potaium finished formulations upon request. The Aminosalicylate Potaium suppliers may include Aminosalicylate Potaium API manufacturers, exporters, distributors and traders.
Aminosalicylate Potaium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aminosalicylate Potaium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aminosalicylate Potaium GMP manufacturer or Aminosalicylate Potaium GMP API supplier for your needs.
A Aminosalicylate Potaium CoA (Certificate of Analysis) is a formal document that attests to Aminosalicylate Potaium's compliance with Aminosalicylate Potaium specifications and serves as a tool for batch-level quality control.
Aminosalicylate Potaium CoA mostly includes findings from lab analyses of a specific batch. For each Aminosalicylate Potaium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aminosalicylate Potaium may be tested according to a variety of international standards, such as European Pharmacopoeia (Aminosalicylate Potaium EP), Aminosalicylate Potaium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aminosalicylate Potaium USP).
LOOKING FOR A SUPPLIER?
